Stocks
Gilead Sciences (GILD) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 16.7% | 41.5% | 24.8% | 32.4% | 38.7% | 0.48% | ||
| Changes by years, y/y, % | -17pp | +25pp | -17pp | +8pp | +6pp | -0.7% | |||
Gilead Sciences. EBITDA margin, %
Gilead Sciences. EBITDA margin, changes, pp
Gilead Sciences (GILD) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 46.5% | -53.0% | 42.9% | -2.53% | 11.8% | 0.48% | |
| Changes by years, y/y, % | +15pp | -85pp | +12pp | -48pp | -34pp | |||
| Changes by quarters, q/q, % | +10pp | -99pp | +96pp | -45pp | +14pp | |||
